HB 2363 Pennsylvania House · 2023-2024 Regular Session

An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment of program, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity, providing for annual report and for list of approved participating pharmacies and further providing for regulations.

This bill amends the Cancer Drug Repository Program Act to clarify definitions and expand the program's scope. It adds specific legal definitions for manufacturers and wholesale distributors and allows approved pharmacies to accept unused prescription drugs from state medical assistance programs for dispensing to patients. The legislation also updates the list of eligible entities that can return or donate drugs to the repository and requires the creation of a list of participating pharmacies. Additionally, the bill includes provisions for program fees, storage regulations, and immunity for participants.
Bill status in committee 3 of 5 stages cleared
Introduction
Jun 2024
Committee Review
Sep 2024
House Passage
Jun 2024
Senate Passage
Governor
Introduced Jun 3, 2024 Last action Sep 23, 2024
Floor votes · House Jun 12, 2024

How they voted

210
Passed
Total votes 21
Jun 12, 2024
D Democratic12
12 Yea
100% Yea
R Republican9
9 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
7
Key actions
3
Committee
3
Amendments
1
Sep 23, 2024
Lower · Passed
Re-reported as committed
lower
Jun 12, 2024
House · Passed
House Vote: pass (21-0)
house
Jun 12, 2024
Committee
Re-committed to Rules
lower
Jun 12, 2024
Lower · Passed
Reported as amended
lower
Jun 3, 2024
Committee
Referred to Health
lower
1 primary · 11 co-sponsors

Sponsors